KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Short term Debt (2023 - 2025)

Historic Short term Debt for Adaptive Biotechnologies (ADPT) over the last 3 years, with Q3 2025 value amounting to $2.4 million.

  • Adaptive Biotechnologies' Short term Debt changed N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $865000.0 for FY2024, which is N/A changed from last year.
  • Per Adaptive Biotechnologies' latest filing, its Short term Debt stood at $2.4 million for Q3 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Short term Debt peaked at $3.2 million during Q3 2023, and registered a low of $865000.0 during Q4 2024.
  • Its 3-year average for Short term Debt is $2.3 million, with a median of $2.4 million in 2025.